Panel Discussion | How important are TAVR Hemodynamics and What to do About It?

Saturday, March 8, 2025

9:04 AM – 9:20 AM ET

Moderator(s)

Ankur Kalra, MD

Interventional Cardiologist
Franciscan Health, United States

Disclosure(s): No financial relationships to disclose
Kimberly A. Skelding, MD, FACC FAHA FSCAI

Division Chief of Cardiovascular Services
RWJ Barnabas Health Jersey City
ridgewood, New Jersey, United States

Disclosure(s): No financial relationships to disclose
Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI

Director Structural Heart, Director Cardiovascular Research, Direct Advanced Cardiac Fellowships.
US Heart & Vascular, Tucson Medical Center

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Hemal Gada, MD

Structural Interventional Cardiologist
UPMC Central PA

Disclosure(s): Abbott Vascular Devices: Consultant (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consultant (Ongoing); innovative cardiovascular solutions: Consultant (Ongoing); Medtronic, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Pi-Cardia: Consultant (Ongoing)
Howard C. Herrmann, MD, FACC, MSCAI

Section Chief Interventional Cardiology
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States

Disclosure(s): Abbott: Grant/Research Support (Ongoing); Affluent Medical: Consultant (Ongoing); Caranx: Consultant (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Massachusetts Medical Society: Editorial consultant (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Microinterventional Devices: Consultant (Ongoing); Shockwave: Grant/Research Support (Ongoing); Wells Fargo: Consultant (Ongoing)
Michael H. Joner, MD

Associate Professor Interventional Cardiology
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

Disclosure(s): No financial relationships to disclose
Arnav Kumar, MD, MSCR

Interventional Cardiologist Structural Heart Valve Specialist Assistant Professor of Medicine
University of Houston, HCA Medical Center
Houston, Texas, United States

Disclosure(s): No financial relationships to disclose
Grant W. Reed, MD, MSc

Program Director, Interventional Cardiology Fellowship
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): Abbott Laboratories: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Ankur Kalra, MD: No financial relationships to disclose

Kimberly A. Skelding, MD, FACC FAHA FSCAI: No financial relationships to disclose

Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI: No financial relationships to disclose

Hemal Gada, MD: Abbott Vascular Devices: Consultant (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consultant (Ongoing); innovative cardiovascular solutions: Consultant (Ongoing); Medtronic, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Pi-Cardia: Consultant (Ongoing)

Howard C. Herrmann, MD, FACC, MSCAI: Abbott: Grant/Research Support (Ongoing); Affluent Medical: Consultant (Ongoing); Caranx: Consultant (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Massachusetts Medical Society: Editorial consultant (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Microinterventional Devices: Consultant (Ongoing); Shockwave: Grant/Research Support (Ongoing); Wells Fargo: Consultant (Ongoing)

Michael H. Joner, MD: No financial relationships to disclose

Arnav Kumar, MD, MSCR: No financial relationships to disclose

Grant W. Reed, MD, MSc: Abbott Laboratories: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)